Area of research
Cancer Research · Oncology
Research interest
Research interests include Peptidase Inhibition and Analysis, Cancer-related molecular mechanisms research, Radiomics and Machine Learning in Medical Imaging, and Signaling Pathways in Disease.
Discovery of W478, a novel SHMT2 inhibitor for the treatment of esophageal carcinoma
The therapeutic effect of Loranthus parasiticus lignan derivatives on collagen-induced arthritis in rats through the SHBG/NFκB pathway
Awareness of intratumoral bacteria and their potential application in cancer treatment
Automated assessment of necrosis tumor ratio in colorectal cancer using an artificial intelligence‐based digital pathology analysis
Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer.
Clinical practice guideline on bladder cancer (Part I)
Clinical practice guideline on bladder cancer (Part II)
Development and validation of a scoring system incorporating tumor growth pattern and perineural invasion for risk stratification in colorectal cancer
Additional file 8 of Single-cell RNA sequencing reveals the potential mechanism of heterogeneity of immunomodulatory properties of foreskin and umbilical cord mesenchymal stromal cells
Additional file 7 of Single-cell RNA sequencing reveals the potential mechanism of heterogeneity of immunomodulatory properties of foreskin and umbilical cord mesenchymal stromal cells
Additional file 6 of Single-cell RNA sequencing reveals the potential mechanism of heterogeneity of immunomodulatory properties of foreskin and umbilical cord mesenchymal stromal cells
Additional file 10 of Single-cell RNA sequencing reveals the potential mechanism of heterogeneity of immunomodulatory properties of foreskin and umbilical cord mesenchymal stromal cells
Additional file 9 of Single-cell RNA sequencing reveals the potential mechanism of heterogeneity of immunomodulatory properties of foreskin and umbilical cord mesenchymal stromal cells
Imaging Biomarkers to Predict and Evaluate the Effectiveness of Immunotherapy in Advanced Non-Small-Cell Lung Cancer
Delivery of Cationic Platinum Prodrugs via Reduction Sensitive Polymer for Improved Chemotherapy
LncRNA POU3F3 Contributes to Dacarbazine Resistance of Human Melanoma Through the MiR-650/MGMT Axis.
Elevated LOXL2 expression by LINC01347/miR-328-5p axis contributes to 5-FU chemotherapy resistance of colorectal cancer.
2021cited by 12position: contributor
Ligustrazine reverts anthracycline chemotherapy resistance of human breast cancer by inhibiting JAK2/STAT3 signaling and decreasing fibrinogen gamma chain (FGG) expression.
2020cited by 15position: contributor
The Improvement of Immune Effect of Recombinant Human Beta-Defensin 2 on Hepatitis B Vaccine in Mice
Curcumin attenuates collagen-induced rat arthritis via anti-inflammatory and apoptotic effects
Down-regulation of testes-specific protease 50 induces apoptosis in human laryngocarcinoma HEp2 cells in a NF-κB-mediated pathway